Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Doppler Signals Changes in Response to Cardiac Resynchronization in Heart Failure Patients

NCT02179203 is registered in ClinicalTrials.gov with Echosense Ltd. as lead sponsor.

NCT NCT02179203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02179203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Doppler Signals Changes in Response to Cardiac Resynchronization in Heart Failure Patients
Lead sponsor
Echosense Ltd.
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
August 31, 2015
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

change in lds signals due to cardiac synchronization therapy